Crossmark

Hsa_circ_0011292 regulates paclitaxel resistance partially through regulating CDCA4 expression by serving as a miR-3619-5p sponge in non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s13273-022-00269-3

Published Online: 2022-07-22

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bao, Yanan

Cui, Yue

Luan, Yumin https://orcid.org/0000-0003-0522-1446
License Information

Text and Data Mining valid from 2022-07-22

Version of Record valid from 2022-07-22
More Information

Article History

Accepted: 27 June 2022

First Online: 22 July 2022

Declarations

:

: Yanan Bao declares that he/she has no conflict of interest. Yue Cui declares that he/she has no conflict of interest. Yumin Luan declares that he/she has no conflict of interest.

: Written informed consent was obtained from patients with approval by the Institutional Review Board in The First Affiliated Hospital of Kunming Medical University.

: Not applicable.

Document is current

Any future updates will be listed below